Outlook Therapeutics, Inc.·4

Dec 3, 4:32 PM ET

Dagnon Terry 4

4 · Outlook Therapeutics, Inc. · Filed Dec 3, 2021

Insider Transaction Report

Form 4
Period: 2021-12-03
Dagnon Terry
Chief Operating Officer
Transactions
  • Purchase

    Common Stock

    2021-12-03$1.42/sh+10,000$14,2001,137,857 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION